Quicksilver Biosciences is developing a new molecular sensing technology with applications for medical diagnostics, toxicology and chemical sensing. The technology makes use of CMOS integrated arrays of nanosensors which report time encoded binding events at the surface of our prototype chips. The detection mechanism is an all-electronic approach using no enzymes, dyes or tags.